Inhibikase Therapeutics (IKT)
Inhibikase Therapeutics (IKT) on the public record today: 1 item across Short interest, each linked to its public source.
Last updated: .
Short interest
- IKT: 31.1 days of average volume to cover the shares sold short at the 15 Oct settlement — 19.6M shares sold short, +1.0% since the 30 Sep settlement · Short interest at or above 98% of its last 49 settlements (2 years) · Days to cover is shares sold short over average daily volume, as FINRA reports it … (FINRA (equity short interest), 14 Oct 2026) IKT